 Eric Earley
Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Artificial Limbs | 11 | 2024 | 173 | 4.060 |
Why?
| | Feedback, Sensory | 5 | 2023 | 23 | 1.590 |
Why?
| | Amputees | 3 | 2024 | 82 | 1.440 |
Why?
| | Erythrocytes | 7 | 2025 | 673 | 1.440 |
Why?
| | Prosthesis Implantation | 5 | 2024 | 143 | 1.080 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 513 | 1.030 |
Why?
| | Electromyography | 6 | 2024 | 381 | 0.960 |
Why?
| | Bionics | 2 | 2024 | 12 | 0.950 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2024 | 32 | 0.920 |
Why?
| | Introns | 1 | 2024 | 251 | 0.840 |
Why?
| | Prosthesis Design | 7 | 2024 | 306 | 0.770 |
Why?
| | Hemolysis | 5 | 2025 | 199 | 0.720 |
Why?
| | Cochlear Implantation | 1 | 2022 | 88 | 0.690 |
Why?
| | Cochlear Implants | 1 | 2022 | 104 | 0.690 |
Why?
| | Joints | 1 | 2018 | 101 | 0.570 |
Why?
| | Movement | 5 | 2022 | 269 | 0.550 |
Why?
| | Forearm | 1 | 2017 | 117 | 0.530 |
Why?
| | Psychomotor Performance | 1 | 2019 | 313 | 0.520 |
Why?
| | Hand | 4 | 2023 | 155 | 0.500 |
Why?
| | Phantom Limb | 2 | 2024 | 5 | 0.430 |
Why?
| | Pattern Recognition, Automated | 1 | 2014 | 75 | 0.420 |
Why?
| | Blood Preservation | 3 | 2025 | 271 | 0.400 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 639 | 0.370 |
Why?
| | Electrodes, Implanted | 4 | 2023 | 106 | 0.330 |
Why?
| | Robotics | 2 | 2023 | 93 | 0.330 |
Why?
| | Humans | 26 | 2025 | 129266 | 0.260 |
Why?
| | Feedback | 2 | 2023 | 162 | 0.250 |
Why?
| | Communicable Diseases, Emerging | 1 | 2025 | 32 | 0.230 |
Why?
| | Learning | 2 | 2019 | 401 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 1 | 2025 | 30 | 0.230 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2025 | 56 | 0.230 |
Why?
| | Diazooxonorleucine | 1 | 2024 | 1 | 0.220 |
Why?
| | Carnitine | 1 | 2024 | 76 | 0.220 |
Why?
| | Boron Compounds | 1 | 2024 | 22 | 0.220 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 26 | 0.220 |
Why?
| | Blood Donors | 1 | 2025 | 96 | 0.220 |
Why?
| | Uric Acid | 1 | 2025 | 161 | 0.210 |
Why?
| | Neuroblastoma | 1 | 2024 | 151 | 0.210 |
Why?
| | Calcium-Binding Proteins | 1 | 2024 | 211 | 0.210 |
Why?
| | Immunoconjugates | 1 | 2024 | 103 | 0.210 |
Why?
| | Arginine | 1 | 2024 | 265 | 0.200 |
Why?
| | Glycine | 1 | 2024 | 165 | 0.200 |
Why?
| | Erythrocyte Transfusion | 1 | 2025 | 181 | 0.200 |
Why?
| | Sensation | 1 | 2023 | 51 | 0.200 |
Why?
| | Exercise Tolerance | 1 | 2025 | 273 | 0.200 |
Why?
| | Elbow | 1 | 2023 | 55 | 0.200 |
Why?
| | Physical Conditioning, Animal | 1 | 2025 | 229 | 0.200 |
Why?
| | Glycolysis | 1 | 2024 | 311 | 0.200 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2024 | 181 | 0.200 |
Why?
| | Wrist | 1 | 2023 | 54 | 0.200 |
Why?
| | Electric Impedance | 1 | 2022 | 102 | 0.190 |
Why?
| | Neoplasm Proteins | 1 | 2025 | 422 | 0.190 |
Why?
| | Arm | 1 | 2022 | 107 | 0.180 |
Why?
| | Quality of Life | 2 | 2023 | 2687 | 0.180 |
Why?
| | Self Concept | 1 | 2022 | 237 | 0.170 |
Why?
| | Monitoring, Physiologic | 1 | 2022 | 265 | 0.170 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2024 | 2063 | 0.170 |
Why?
| | Biomedical Research | 1 | 2025 | 637 | 0.150 |
Why?
| | Membrane Proteins | 1 | 2024 | 1117 | 0.150 |
Why?
| | Acclimatization | 1 | 2019 | 165 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2019 | 336 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 546 | 0.140 |
Why?
| | Task Performance and Analysis | 1 | 2017 | 173 | 0.130 |
Why?
| | Mice | 7 | 2025 | 16915 | 0.120 |
Why?
| | Male | 9 | 2025 | 63512 | 0.120 |
Why?
| | Aging | 1 | 2024 | 1774 | 0.110 |
Why?
| | Motor Activity | 1 | 2018 | 675 | 0.110 |
Why?
| | Mice, SCID | 2 | 2024 | 350 | 0.110 |
Why?
| | Wrist Joint | 1 | 2014 | 64 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 3968 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 144 | 0.100 |
Why?
| | Hand Strength | 1 | 2014 | 113 | 0.100 |
Why?
| | Upper Extremity | 2 | 2022 | 95 | 0.090 |
Why?
| | Pain Measurement | 2 | 2024 | 506 | 0.090 |
Why?
| | Female | 8 | 2025 | 68551 | 0.090 |
Why?
| | Animals | 7 | 2025 | 35309 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2024 | 1875 | 0.080 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 12 | 0.060 |
Why?
| | Proteogenomics | 1 | 2024 | 3 | 0.060 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.060 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 151 | 0.060 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 9 | 0.060 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.060 |
Why?
| | Erythrocyte Aging | 1 | 2024 | 13 | 0.060 |
Why?
| | Proteasome Inhibitors | 1 | 2024 | 42 | 0.050 |
Why?
| | Heterografts | 1 | 2024 | 131 | 0.050 |
Why?
| | Isoenzymes | 1 | 2024 | 302 | 0.050 |
Why?
| | Middle Aged | 4 | 2025 | 31090 | 0.050 |
Why?
| | Titanium | 1 | 2023 | 76 | 0.050 |
Why?
| | Iron | 1 | 2025 | 281 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2025 | 352 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2024 | 851 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 321 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2024 | 588 | 0.050 |
Why?
| | Electric Stimulation | 1 | 2023 | 269 | 0.050 |
Why?
| | Adult | 4 | 2025 | 35495 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2025 | 349 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2024 | 295 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2024 | 478 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 812 | 0.050 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 390 | 0.050 |
Why?
| | Aged | 3 | 2024 | 22032 | 0.050 |
Why?
| | Activities of Daily Living | 1 | 2024 | 381 | 0.040 |
Why?
| | Anemia, Sickle Cell | 1 | 2024 | 252 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 592 | 0.040 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2117 | 0.040 |
Why?
| | Metabolomics | 1 | 2025 | 652 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 1965 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1344 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 873 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1266 | 0.040 |
Why?
| | Proteomics | 1 | 2025 | 1054 | 0.040 |
Why?
| | Lower Extremity | 1 | 2022 | 404 | 0.040 |
Why?
| | Biomarkers, Tumor | 1 | 2024 | 1173 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1327 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3202 | 0.030 |
Why?
| | Pandemics | 1 | 2025 | 1481 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1933 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1613 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4057 | 0.030 |
Why?
| | Child | 2 | 2024 | 20785 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2024 | 10202 | 0.020 |
Why?
|
|
Earley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|